CMS has spent months cracking down on suspected fraud among durable medical equipment suppliers, sharing two major updates in recent weeks: a new round of Medicare Advantage payment bars and the expiration of a six-month enrollment moratorium.
Here are 10 numbers to know about the DME fraud crackdown:
11. The number of DMEPOS suppliers CMS announced Sept. 8 it is barring from earning future Medicare Advantage Part C and Part D payments, citing improper billing practices.
$3.4 billion. The amount of suspected fraudulent billing tied to those 11 suppliers in 2025 and 2026, according to CMS. The agency said the companies billed for deceased beneficiaries’ equipment and supplied devices to beneficiaries who never requested or received them.
4. The number of those 11 suppliers that had already lost their original Medicare billing privileges before shifting to billing Medicare Advantage plans instead.
6 months. The length of the nationwide DMEPOS enrollment moratorium, which went into effect Feb. 27 and expired Aug. 27. It blocked new Medicare enrollment and certain ownership changes for medical supply companies.
$1.5 billion. The amount of suspected fraudulent DMEPOS billing CMS said it stopped in the year before it imposed the moratorium, part of the justification for the enrollment freeze.
79,000+.The number of approved DMEPOS suppliers nationwide, which CMS cited to argue the moratorium would not disrupt beneficiaries’ access to care.
17%. The revocation rate for medical supply company specialties from 2023 to 2025, nearly triple the rate for other DMEPOS supplier types, according to CMS data.
$100,000. The new bid surety bond amount for the DMEPOS Competitive Bidding Program’s Remote Item Delivery track, up from $50,000, finalized under the fiscal year 2027 Inpatient Rehabilitation Facilities Prospective Payment System rule.
5,586. The number of providers and suppliers that had their Medicare billing privileges revoked in 2025 as part of CMS’ broader fraud enforcement push, which also suspended $5.7 billion in suspected fraudulent payments.
$1.3 billion. The amount in fraudulent DME claims one Pennsylvania company, ND Medical Solutions, allegedly submitted to Medicare and other payers over just five months in 2025, part of the Justice Department’s Operation Gold Rush case against an alleged foreign money launderer indicted Sept. 4, according to a DOJ news release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
